Bought huge amount in this company today. No better buying time. Not sure what the fuss is about with the big price drop. Phase 2 study is never powered to see how efficacious the treatment is....
- Forums
- ASX - By Stock
- DXB
- Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study, page-169
-
- There are more pages in this discussion • 459 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
52.5¢ |
Change
0.050(10.5%) |
Mkt cap ! $275.1M |
Open | High | Low | Value | Volume |
47.5¢ | 53.0¢ | 47.5¢ | $1.764M | 3.473M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 48853 | 52.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
53.0¢ | 175839 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 48853 | 0.520 |
5 | 166014 | 0.515 |
7 | 117235 | 0.510 |
7 | 82071 | 0.505 |
6 | 92874 | 0.500 |
Price($) | Vol. | No. |
---|---|---|
0.530 | 175839 | 13 |
0.535 | 138723 | 5 |
0.540 | 190208 | 11 |
0.545 | 132509 | 4 |
0.550 | 104280 | 6 |
Last trade - 12.23pm 16/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online